Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
European Urology|January 20, 2016
A Phase 2 Randomized Controlled Trial of Personalized Peptide Vaccine Immunotherapy with Low-dose Dexamethasone Versus Dexamethasone Alone in Chemotherapy-naive Castration-resistant Prostate CancerKazuhiro Yoshimura, Takafumi Minami, Masahiro Nozawa, et al.
Research and Reports in Urology|January 9, 2014
Therapeutic efficacy and anti-inflammatory effect of ramelteon in patients with insomnia associated with lower urinary tract symptomsNobutaka Shimizu, Masahiro Nozawa, Koichi Sugimoto, et al.
Translational Andrology and Urology|January 12, 2023
Comparison of molecular profiles of upper tract urothelial carcinoma vs. urinary bladder cancer in the era of targeted therapy: a narrative reviewEisuke Tomiyama, Kazutoshi Fujita, Mamoru Hashimoto, et al.
Research and Reports in Urology|September 2, 2017
Acotiamide hydrochloride hydrate added to combination treatment with an α-blocker and a cholinergic drug improved the QOL of women with acute urinary retention: case seriesKoichi Sugimoto, Takahiro Akiyama, Nobutaka Shimizu, et al.
International Journal of Clinical Oncology|December 24, 2015
Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinomaMasahiro Nozawa, Koichi Sugimoto, Takayuki Ohzeki, et al.
Lower Urinary Tract Symptoms|March 19, 2016
Efficacy of Adding Dutasteride to α-Blocker Therapy Treated Benign Prostatic Hyperplasia Patients with Small Volume Prostate (<30 mL)Mamoru Hashimoto, Nobutaka Shimizu, Koichi Sugimoto, et al.
IJU Case Reports|November 6, 2023
A case of neuroendocrine tumor at the external urethral meatus after total cystectomyKoji Miki, Kazutoshi Fujita, Ken Kuwahara, et al.
Anticancer Research|June 26, 2024
Impact of Novel Agents on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Metastatic Castration-resistant Prostate CancerYutaka Yamamoto, Mituhisa Nishimoto, Yasunori Akashi, et al.
Cancers|December 23, 2023
Prognostic Factors of Platinum-Refractory Advanced Urothelial Carcinoma Treated with PembrolizumabYasunori Akashi, Yutaka Yamamoto, Mamoru Hashimoto, et al.
International Immunopharmacology|March 4, 2014
Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinomaTakafumi Minami, Tomoko Minami, Nobutaka Shimizu, et al.
Pageof 9